Home > Cashflow Statement > ORCHID PHARMA

ORCHID PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹25 Cr₹167 Cr₹31 Cr₹-217 Cr₹-165 Cr

What is the latest Cash Flow from Financing Activities ratio of ORCHID PHARMA ?

The latest Cash Flow from Financing Activities ratio of ORCHID PHARMA is ₹25 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹25 Cr
Mar2024₹167 Cr
Mar2023₹31 Cr
Mar2022₹-217 Cr
Mar2021₹-165 Cr

How is Cash Flow from Financing Activities of ORCHID PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹25 Cr
-84.90
Mar2024 ₹167 Cr
435.97
Mar2023 ₹31 Cr
Positive
Mar2022 ₹-217 Cr
Negative
Mar2021 ₹-165 Cr -

Compare Cash Flow from Financing Activities of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,388.8 Cr -1.1% -4.2% -46.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr 1.6% 4.6% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 3.1% 5.9% 39% Stock Analytics
CIPLA ₹108,978.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 0.5% 9.8% 5.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-1.1%

-4.2%

-46.2%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses